MedPath

Jadelle

Brand Name: Jadelle

Generic Name: Levonorgestrel

Active
Registration Number

DR-XY48818

Dosage Form

Implant (For Subdermal Use Only)

Issuance Date

July 31, 2023

Expiry Date

July 21, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength75mg
PackagingOne (1) set contains two (2) implants in peelable film bag (White side: Adhesive coated nonwoven material of Polyethylene (PE) and Transparent side: Polyethylene terephthalate/Polyethylene [PET/PE] (Box of 10 sets) + Disposable sterile single use trocar in PE/Polyamide Paper film x 1's (Box of 10'S)

Classification

C
Classification
Prescription (RX) Drug
A
Application
Monitored Release (MR) (Re-application)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

LevonorgestrelActive
Monograph: Levonorgestrel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform